Stay updated with breaking news from Peter Bains. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
'Peter has a comprehensive understanding of the Biocon Group, having led Syngene for 5 years, taking it through its very successful IPO in 2015,' says Mazumdar-Shaw
Biocon appoints Peter Bains as group CEO, effective immediately. Bains has over 30 years of global experience in leadership roles.
A Lanarkshire-based biotech firm is strengthening its presence in the animal healthcare market, where it sees strong potential, by inking a tie-up that it says will progress its product to treat a condition causing itchy skin in dogs.
A Scottish biotechnology company specialising in anti-viral treatments has flagged its intention to raise further investment ahead of a possible…
ILC's Alfacyte product has potential to become a game-changing antiviral treatment in the ongoing global fight against Covid-19 Scottish biotech ICL Therapeutics has set its sights on a Series A round